Today: 10 June 2026
Netflix stock dips as UK antitrust pressure mounts on Warner bid and Senate hearing nears
27 January 2026
2 mins read

Netflix stock dips as UK antitrust pressure mounts on Warner bid and Senate hearing nears

NEW YORK, Jan 27, 2026, 11:00 EST — Regular session

  • Shares of Netflix slipped roughly 1.2% in late morning deals amid growing political scrutiny over its Warner bid
  • UK politicians pressed the CMA to launch a full competition review, intensifying the growing regulatory pressure
  • A Wall Street analyst’s upgrade yesterday provided only modest backing, as deal risk continues to weigh on sentiment

Netflix shares dipped Tuesday as British lawmakers called on the UK’s competition authority to scrutinize the streamer’s proposed Warner Bros Discovery deal. The dispute is increasingly taking on a political edge, overshadowing financial concerns.

Netflix slipped 1.2% to $84.70 by 11:00 a.m. EST, surrendering earlier gains as investors questioned if the deal’s timeline is dragging out once more.

Why this matters now: the stock has turned into a stand-in for regulatory risk linked to the Warner bid, as investors weigh the chances the deal will face drawn-out reviews across multiple jurisdictions, potentially lasting months and demanding concessions.

Any forced delay sparks follow-up concerns — financing, management attention, and whether Netflix might have to cough up more to secure the deal if competing bids and political hurdles continue to swirl.

Over a dozen British politicians and former policymakers have urged the Competition and Markets Authority to conduct a full review, warning the deal would “cement an already dominant player” in TV streaming and risk “a substantial lessening of competition,” Reuters reported. The letter, dated Jan. 23, was addressed to CMA chief executive Sarah Cardell, according to Reuters. Source

The CMA declined to speculate on cases not under formal investigation, Reuters reported. Netflix and Warner did not immediately reply to Reuters’ requests for comment.

Senator Mike Lee, chair of the Senate Judiciary antitrust subcommittee, has zeroed in on the deal and set a hearing for Feb. 3, The Capitol Forum reports. Lee cautioned that the review process could be “misused” to bog down a competitor, dubbing the tactic a “killer non-acquisition”—a merger attempt that damages a rival even if it never goes through. Source

Warner’s camp fired back. A Warner Bros spokesperson commended Netflix for its “hard” efforts to finalize the deal and emphasized that Warner “continues to operate as a fully independent company,” The Capitol Forum reported.

Just a day earlier, Phillip Securities analyst Helena Wang raised Netflix’s rating from “Sell” to “Accumulate,” boosting her price target to $100. She highlighted Netflix’s “clear leadership” in video-on-demand and its strong pricing power, according to a note cited by TheFly. (An “Accumulate” rating suggests investors should add shares gradually rather than buy aggressively.) Source

Warner Bros Discovery shares held steady at $28.24. Meanwhile, rival bidder Paramount Skydance dropped 3.2%, closing at $11.51, highlighting how fast deal chatter ripples through the sector.

The risk is straightforward: should regulators launch deeper investigations or signal strong resistance, Netflix’s bid might come with strings attached that dilute its strategic value — or drag out the process, leaving the stock driven more by news than by earnings.

Investors are turning to the Feb. 3 Senate hearing highlighted by The Capitol Forum. Signals from UK regulators on whether the CMA will launch a formal review could shape the next move for NFLX.

Stock Market Today

  • Masimo Corp to Delist from Nasdaq as Per SEC Form 25 Filing
    June 10, 2026, 10:17 AM EDT. Masimo Corp has filed SEC Form 25 to delist its common stock from the Nasdaq Stock Market, signaling removal of its securities from exchange listing and registration. The move, filed under the Securities Exchange Act of 1934, was submitted by Nasdaq on June 10, 2026, and reflects compliance with regulatory requirements for delisting. The filing was certified by Nasdaq's AVP Tara Petta. This action typically indicates strategic changes by the company or voluntary deregistration, affecting investors as the stock will no longer be traded on Nasdaq.

Latest articles

Rigetti Computing Stock Falls as Sale Notice Tests $100 Million Quantum Rally

Rigetti Computing Stock Falls as Sale Notice Tests $100 Million Quantum Rally

10 June 2026
Rigetti Computing plunged 9.55% to $19.69 Tuesday and dipped further premarket after director Ray O. Johnson filed to sell 122,188 shares worth $2.6 million, testing investor confidence following a recent rally on news of a potential $100 million U.S. Commerce Department quantum-computing award, with traders watching for binding funding terms amid ongoing volatility.
PATH slips again, investors keep questioning AI automation bet

PATH slips again, investors keep questioning AI automation bet

10 June 2026
UiPath shares slid 3.76% to $10.75 and dropped another 1.49% pre-market as investors focused on slowing annual recurring revenue growth—up 12% to $1.901 billion versus 17% revenue growth—raising doubts about AI automation’s impact on recurring sales; second-quarter ARR guidance of $1.929–$1.934 billion is now the key number for PATH’s stock direction.
Dow Jones drops 450 points as UnitedHealth sinks on Medicare rates; confidence slumps
Previous Story

Dow Jones drops 450 points as UnitedHealth sinks on Medicare rates; confidence slumps

Apple stock climbs as Wall Street targets shift ahead of Jan. 29 earnings
Next Story

Apple stock climbs as Wall Street targets shift ahead of Jan. 29 earnings

Go toTop